Stockscreener 앱 받기
0.6951
3.79%
-0.0274
전일 마감가:
$0.7225
열려 있는:
$0.6843
하루 거래량:
16,386
Relative Volume:
0.15
시가총액:
$2.16M
수익:
-
순이익/손실:
$-4.14M
주가수익비율:
-0.0959
EPS:
-7.2511
순현금흐름:
$-4.79M
1주 성능:
+5.30%
1개월 성능:
-3.46%
6개월 성능:
-49.99%
1년 성능:
-62.43%
1일 변동 폭
$0.6811
$0.72
1주일 범위
$0.6556
$0.7299
52주 변동 폭
$0.57
$4.25
Bone Biologics Corp Stock (BBLG) Company Profile
명칭
Bone Biologics Corp
전화
(781) 552-4452
주소
2 BURLINGTON WOODS DRIVE,, BURLINGTON
BBLG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
0.7174 | 2.16M | 0 | -4.14M | -4.79M | -7.2511 |
|
ABT
Abbott Laboratories
|
132.25 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.50 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.36 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.41 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.40 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Bone Biologics Corp 주식(BBLG)의 최신 뉴스
Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics - IT News Online
Bone Health: Biocon Biologics Receives Positive CHMP Opinions for Biosimilar Denosumab in Europe - Yahoo Finance
BBLG stock touches 52-week low at $0.57 amid market challenges By Investing.com - Investing.com South Africa
BBLG stock touches 52-week low at $0.57 amid market challenges - Investing.com Australia
Orthobiologics Market Set to Witness Significant Growth - openPR.com
When (BBLGW) Moves Investors should Listen - news.stocktradersdaily.com
BBLG stock touches 52-week low at $0.7 amid market challenges - Investing.com Canada
BBLG stock touches 52-week low at $0.7 amid market challenges By Investing.com - Investing.com South Africa
Bone Biologics (OTC:BBLG) Trading 1.9% Higher – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Bone Biologics sets date for 2025 annual meeting - Investing.com
Top Trend In Orthobiologics Devices And Equipment Market 2025: Biodegradable Implants Transforming Orthobio... - WhaTech
Orthobiologics Market Future Business Opportunities - openPR.com
Theradaptive Welcomes Jeffrey W. Dunn to its Board of Directors - The Malaysian Reserve
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Update - Defense World
Bone Biologics (OTC:BBLG) Trading 1.2% Higher – Here’s Why - Defense World
MTF Biologics Collaborates with Kolosis BIO to Boost DBX Brand - World Business Outlook
MTF Biologics Expands Partnership with Kolosis BIO to Strengthen DBX Brand - StreetInsider.com
TETROUS®, INC. SUCCESSFULLY CLOSES FINANCING ROUND, SECURING ADDITIONAL CAPITAL FOR FUTURE GROWTH - PR Newswire
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Down 15.9% in February - Defense World
BBLG stock touches 52-week low at $0.8 amid market challenges - Investing.com
Orthobiologics Market Generated Opportunities, Future Scope - openPR
BBLG: Funding Looks Good as Trials Continue - Research Tree
Bone Biologics Corp SEC 10-K Report - TradingView
Orthobiologics Market : Comprehensive Overview, Trends, and Future Outlook 2025-2035 - PharmiWeb.com
Key Bone Void Fillers Market Trend 2025-2034: Advancements In Bone Healing Through Carbohydrate Polymer Tec... - WhaTech
Bone Biologics (BBLG) Expected to Release Quarterly Earnings on Wednesday - Defense World
Biodexa Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:BDRX - Benzinga
Bone Biologics (NASDAQ:BBLG) Stock Quotes, Forecast and News Summary - Benzinga
Accuray (ARAY) Stock Surges Amidst Market Activity - GuruFocus.com
Trevi Therapeutics Inc (TRVI) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
OMI’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
CNQ’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
Edison International (EIX) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
BBLG’s Stock Journey: What Investors Need to Know About Bone Biologics Corp’s Performance - The InvestChronicle
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Up 9.8% in January - Defense World
(BBLGW) Technical Pivots with Risk Controls - Stock Traders Daily
Spine Biologics Market Research to 2030: Expansion Fueled - GlobeNewswire
Bone Biologics (OTC:BBLG) Trading Down 6.9% – Here’s Why - Defense World
The Bone Growth Products Market to Hit Revenue of $1.35 Billion by 2029, Mergers & Acquisition Trends Set to Drive Market ExpansionArizton - Industry Today
(BBLGW) Trading Report - Stock Traders Daily
An innovative advance in bone grafting: initial clinical results using a novel integrative bone graft in spinal fusion - Frontiers
Bone Biologics (OTC:BBLG) Trading Up 13% – Should You Buy? - Defense World
(BBLGW) Trading Advice - Stock Traders Daily
What Analysts Think About Bone Biologics Corp (NASDAQ: BBLG)’s Potential Raise - Stocks Register
Head to Head Contrast: Bone Biologics (NASDAQ:BBLG) vs. Establishment Labs (NASDAQ:ESTA) - Defense World
Bone Biologics Corp (BBLG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10.11%
0.04%
자본화:
|
볼륨(24시간):